Inventor
FENG DONG-MEI
US18 patents
⚠️ This page may combine multiple inventors who share the name “FENG DONG-MEI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK & CO INC
14 patentsUS5948750ASep 7, 1999
Conjugates useful in the treatment of prostate cancer
MERCK & CO INC203 citations98
US5866679AFeb 2, 1999
Peptides
MERCK & CO INC87 citations95
US5510369AApr 23, 1996
Pyrrolidine thrombin inhibitors
MERCK & CO INC52 citations95
US6391305B1May 21, 2002
Conjugates useful in the treatment of prostate cancer
MERCK & CO INC78 citations94
US5998362ADec 7, 1999
Conjugates useful in the treatment of prostate cancer
MERCK & CO INC71 citations94
US6174858B1Jan 16, 2001
Conjugates useful in the treatment of prostate cancer
MERCK & CO INC52 citations92
US6143864ANov 7, 2000
Peptides
MERCK & CO INC43 citations92
US5672582ASep 30, 1997
Thrombin inhibitors
MERCK & CO INC27 citations91
US6919343B2Jul 19, 2005
N-biphenyl(substituted methyl) aminocycloalkane-carboxamide derivatives
MERCK & CO INC14 citations83
US6130204AOct 10, 2000
Peptides
MERCK & CO INC12 citations73
US5714485AFeb 3, 1998
Piperidine and hexahydropyridazine thrombin inhibitors
MERCK & CO INC7 citations73
US5681926AOct 28, 1997
Thrombin receptor binding peptides
MERCK & CO INC2 citations62
US5457177AOct 10, 1995
Thrombin receptor radioligands
MERCK & CO INC4 citations62
US7091380B2Aug 15, 2006
N-biphenylmethyl aminocycloalkanecarboxamide derivatives
MERCK & CO INC2 citations51
UNIV TEXAS
3 patentsUS5470947ANov 28, 1995
CHRH antagonists with low histamine release
UNIV TEXAS21 citations91
US4935491AJun 19, 1990
Effective antagonists of the luteinizing hormone releasing hormone which release negligible histamine
UNIV TEXAS27 citations91
US5763404AJun 9, 1998
Methods for using LHRH antagonists with low histamine release
UNIV TEXAS0 citations48